Is Gossamer Bio, Inc. (GOSS) a Buy, Sell, or Hold?
NASDAQ : GOSS
Gossamer Bio, Inc.
$0.1701 USD
$0.0 (-0.23%)
- Volume
- 11.51M
- Average Volume
- 13.72M
- Market Capitalization
- $39.9M
- P/E Ratio
- -0.22
- Dividend Yield
- 0.00%
- Price Target
- $1.00
- Year High
- $3.87
- Year Low
- $0.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.20
Insider Activity Summary (Last 12 Months)
Insiders Buying
77
Insiders Selling
40
Amount of Insider Selling
$16.59M
GOSS Insider Buying/Selling by Quarter
GOSS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Quisel John D | director | 2026-06-04 | A-Award | 0.178 | 2026-06-05 |
| Drynan Skye | director | 2026-06-04 | A-Award | 0.178 | 2026-06-05 |
| Daniel Thomas O | director | 2026-06-04 | A-Award | 0.178 | 2026-06-05 |
| Cox Russell J. | director | 2026-06-04 | A-Award | 0.178 | 2026-06-05 |
| Milligan Sandra | director | 2026-06-04 | A-Award | 0.178 | 2026-06-05 |
| Nathan Steven D | director | 2026-06-04 | A-Award | 0.178 | 2026-06-05 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 1.21 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 0.838 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 0.97 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 1.13 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 1.36 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 2.88 | 2026-03-20 |
| Aranda Richard | officer: Chief Medical Officer | 2026-03-19 | D-Return | 2.16 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 0.97 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 1.13 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 1.36 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 2.88 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 2.16 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 1.21 | 2026-03-20 |
| Peterson Caryn | officer: EVP, Regulatory Affairs | 2026-03-19 | D-Return | 0.838 | 2026-03-20 |
| Smith Robert Paul JR | officer: Chief Commercial Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Smith Robert Paul JR | officer: Chief Commercial Officer | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Smith Robert Paul JR | officer: Chief Commercial Officer | 2026-03-19 | D-Return | 1.13 | 2026-03-20 |
| Smith Robert Paul JR | officer: Chief Commercial Officer | 2026-03-19 | D-Return | 2.88 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 22.1 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 11.94 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 2.16 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 1.21 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 9.79 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 0.97 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 1.13 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 2.88 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 0.838 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-03-19 | D-Return | 12.1 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 1.21 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 0.838 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 0.97 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 1.13 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 1.36 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 2.88 | 2026-03-20 |
| Giraudo Bryan | officer: COO/CFO | 2026-03-19 | D-Return | 2.16 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | A-Award | 0.45 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 2.88 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 1.13 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 0.97 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 0.838 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 1.21 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 2.16 | 2026-03-20 |
| Christian Waage | officer: EVP, Tech Ops and Admin | 2026-03-19 | D-Return | 1.36 | 2026-03-20 |
| Hasnain Faheem | director, officer: President & CEO | 2026-01-02 | A-Award | 2.88 | 2026-01-05 |
| Hasnain Faheem | director, officer: President & CEO | 2026-01-02 | A-Award | 0 | 2026-01-05 |